Background: Cancer is the third leading cause of death in Kenya. Yet, little is known about prognostic awareness and preferences for prognostic information.
Aim: To assess the prevalence of prognostic awareness and preference for prognostic information among advanced cancer patients in Kenya.
Setting: Ou...
Objective
To determine if the prevalence of schistosomiasis in children aged 9–12 years is associated with the prevalence in 5–8-year-olds and adults after preventive chemotherapy in schools or the community.
Methods
We combined data from four community-randomized, preventive chemotherapy trials in t...
ntroduction: Trauma is a leading cause of morbidity and mortality in Kenya. In many countries, substance use is common among patients presenting with injuries to an emergency center (EC).
Objective: To describe the epidemiology of self-reported substance use among adult injured patients seeking ED care i...
BACKGROUND
Maternal complications during pregnancy and labor have been the leading
cause of maternal and neonatal death globally. The aim of the study was to observe
and compare the differences in the perinatal outcomes of newborns born to women
with maternal complications to those born to women witho...
Highly Active Antiretroviral Therapy (HAART) is undoubtedly the only
proven remedy known to improve the health outcomes and reduce AIDS-related
mortality. However, just like other chronic diseases, HIV presents significant
challenges in achieving and maintaining adherence to medication. The effectivene...
Pregnant women constitute a promising sentinel group for continuous monitoring of malaria transmission. To identify antibody signatures of recent Plasmodium falciparum exposure during pregnancy, we dissected IgG responses against VAR2CSA, the parasite antigen that mediates placental sequestration. We use...
Background: Intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP) is recommended for malaria prevention in HIV-negative pregnant women, but it is contraindicated in HIV-infected women taking daily cotrimoxazole prophylaxis (CTXp) because of potential added risk of adve...
